Porcine Recombinant NK-Lysin Inhibits the Growth and Metastasis of Murine Hepatocellular Carcinoma In Vivo
Molecules · 2025
DOI: 10.3390/molecules30061234 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Kuohai Fan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shanxi Key Laboratory for Modernization of TCVM, College of Veterinary Medicine, Shanxi Agricultural University, Taigu 030801, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Recombinant Proteins, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanxi Provincial Key Research and Development Project, China.
Abstract (Originalsprache)
Porcine recombinant NK-lysin (prNK-lysin) has been shown to inhibit the proliferation and metastasis of hepatocellular carcinoma (HCC) cells in vitro. However, its effects on the proliferation and metastasis of HCC cells in vivo remain unclear. In this study, an allograft murine model using the murine HCC cell line Hepa1-6 was employed to investigate the anticancer effects of prNK-lysin. Initially, the in vitro anticancer efficacy of prNK-lysin was evaluated in Hepa1-6 cells, demonstrating that prNK-lysin effectively inhibited both proliferation and metastasis. These effects were mediated through the induction of oncosis and suppression of Fascin-1, MMP-2, and MMP-9 protein expressions. Subsequently, the in vivo anticancer efficacy of prNK-lysin was assessed using a mouse liver orthotopic implantation model and a lung metastasis model of Hepa1-6 cells in BALB/cA-nu mice. The administration of 13 mg/kg of prNK-lysin could inhibit tumor growth in the liver and metastasis to the lungs. Our results demonstrate that prNK-lysin possesses strong anti-HCC effects both in vitro and in vivo, with the induction of oncosis and the inhibition of Fascin-1, MMP-2, and MMP-9 protein expressions as potential molecular mechanisms for its anticancer activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanxi Key Laboratory for Modernization of TCVM, College of Veterinary Medicine, Shanxi Agricultural University, Taigu 030801, China.
- Laboratory Animal Center, Shanxi Agricultural University, Taigu 030801, China.
- Medical Research Council (MRC) Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh EH16 4TJ, UK.
Förderung
- Shanxi Provincial Key Research and Development Project, China
Zitieren
APA
Fan, K., Feng, Z., Zhao, D., Zheng, X., Yin, W., Sun, N., Sun, P., & Li, H. (2025). Porcine Recombinant NK-Lysin Inhibits the Growth and Metastasis of Murine Hepatocellular Carcinoma In Vivo. Molecules. https://doi.org/10.3390/molecules30061234
Vancouver
Fan K, Feng Z, Zhao D, Zheng X, Yin W, Sun N, et al. Porcine Recombinant NK-Lysin Inhibits the Growth and Metastasis of Murine Hepatocellular Carcinoma In Vivo. Molecules. 2025. doi:10.3390/molecules30061234
BibTeX
@article{Fan2025,
author = {Fan, Kuohai and Feng, Zhiwei and Zhao, Dahai and Zheng, Xiaozhong and Yin, Wei and Sun, Na and Sun, Panpan and Li, Hongquan},
title = {Porcine Recombinant NK-Lysin Inhibits the Growth and Metastasis of Murine Hepatocellular Carcinoma In Vivo},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30061234}
}
EUVIMED